MABVAX THERAPEUTICS HOLDINGS, INC.·4

Feb 8, 4:03 PM ET

MABVAX THERAPEUTICS HOLDINGS, INC. 4

4 · MABVAX THERAPEUTICS HOLDINGS, INC. · Filed Feb 8, 2017

Insider Transaction Report

Form 4
Period: 2017-02-06
Resnick Paul F
Vice President, CBO
Transactions
  • Award

    Option to Purchase Common Stock

    2017-02-06$2.99/sh+35,000$104,65035,000 total
    Exercise: $2.99Exp: 2027-02-06Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]The Option Shares shall vest in three equal annual installments commencing on the first anniversary of the Vesting Commencement Date.

Documents

1 file
  • 4
    form4-02082017_010233.xmlPrimary